Evidence map›Paper›PMID 39494764›Full record

ReviewWomen's health (London, England)

High-intensity focused ultrasound in adenomyosis treatment: Insights on safety, efficacy, and reproductive prospects.

Shadha Nasser Bahutair, Laila Yahya Alhubaishi

Abstract readReview
In one paragraph

Review in Women's health (London, England). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shadha Nasser BahutairObstetrics and Gynecology, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.ORCID 0009-0002-6427-1355
Laila Yahya AlhubaishiObs&gyne and uro-gynecologist Dubai Health Latifa hospital, Dubai, United Arab Emirates Consultant Obs&gyne and uro-gynecologist Dubai Health-Latifa hospital Chairperson of scientific committee of Obs&gyne Emirati board In NIHS-UAE University.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The management of adenomyosis has undergone significant evolution, moving from traditional surgical interventions like hysterectomy to more conservative methods aimed at preserving fertility. Essential roles have been played by uterine-sparing surgeries and uterine artery embolization. Despite these advancements, there is a growing interest in less invasive alternatives. This review delves into the potential of high-intensity focused ultrasound (HIFU). HIFU employs focused ultrasound waves for precise ablation of adenomyotic lesions. The review conducts a thorough analysis of HIFU principles, safety, efficacy, and its possible synergies with other therapies. HIFU seems to be effective for adenomyosis treatment, demonstrating a favorable adverse effect profile and suitability for fertility preservation. Combining HIFU with hormonal treatment appears to enhance long-term symptom control, presenting a promising and comprehensive approach for managing adenomyosis. The goal of this article is to develop a comprehensive understanding of HIFU's role in contemporary adenomyosis management and to explore areas requiring further research.

Indexed as

AdenomyosisFertility PreservationHigh-Intensity Focused Ultrasound AblationFemaleHumansTreatment OutcomeUterusadenomyosisfertility preservationhigh-intensity focused ultrasoundmagnetic resonance imagingnon-invasivethermal ablationultrasonographyuterus sparing

Identifiers

PMID39494764
PMCPMC11536486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.